Immunoglobulin (Ig) A antibodies to Bacteroides fragilis and Escherichia coli in breast fluids and serum of lactating women, and IgG antibodies to E. coli in cord and maternal sera of mother-infant pairs were measured by a radioimmunoassay. Antibody concentrations were expressed as micrograms of antibody per milliliter or per milligram of IgA or IgG. For concentrations (mean f SD) of IgA antibodies, see Table 1 .
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Concentrations of secretory IgA in breast fluids were 36.7 + 25.3 mglml o n day 1, 1.66 f mg/ml on day 4, and 0.7 1 + 0.31 mglml 6 weeks after delivery. Both the amount of IgA antibodies (pglml) and total IgA in colostrum fell abruptly and reached serum levels b y the 4th postpartum day. The 23-30-fold greater quantity of IgA antibodies per milliliter for day 1 colostrum than IgA antibodies per milliliter of serum a t delivery corresponded t o a 21-fold higher total concentration of IgA in colostrum than in serum at these times. Concentrations of antibodies t o B. fragilis and E. coli were not significantly different.
Concentrations of IgG antibodies t o E. coli in 1 0 maternal sera at delivery (2.1 f 1.6 pg/ml; 0.33 f 0.29 pg/mg IgG) were slightly but not significantly lower than those in corresponding cord sera (2.5 * 2.0 pglml; 0.29 f 0.22 pg/mg IgG).
Concentrations of serum IgA anti-E. coli antibodies were similar in nursing and non-nursing mothers both at delivery and 6 weeks later, and these concentrations were similar to those in nonpregnant women.
Findings of the study indicate that (1) the large quantities 
Speculation
During lactation, the breast synthesizes IgA with constant levels of specific antibodies to commensal intestinal bacteria.
Ingested breast fluid antibodies to B. fragilis could suppress growth of Bacteroides in the gut and account for the relatively low numbers of these anaerobes in intestinal content of breast-fed infants.
The human breast secretes antibodies t o some intestinal microorganisms (1, 9, 14, 19, 20) . The antibodies may help t o protect breast-fed infants from enteric infections (12, l a ) , and determine the composition of the indigenous gut microflora (20, 24) . Although such antibodies have been recognized for years, details concerning their biologic activities and the mechanisms by which they are synthesized and secreted are incompletely understood. This is due partly t o limitations in methods used in their study. With the exception of some immunofluorescence studies ( 6 ) , the antibodies have been evaluated only by complex antigen-antibody reactions such as agglutination or bactericidal activity (1, 9, 14, 19) . None of these methods has measured the antibodies quantitatively, and often the immunoglobulin classes t o which the antibodies belong have not been defined. It is well established, however, that the breast participates in the immunologic system of external secreting organs in which the principal immunoglobulin is 11 S exocrine IgA (2, 4, 25) .
This laboratory recently developed radioimmunologic methods, based upon the primary binding of antibodies t o bacteria, for quantitative measurement of naturally occurring antibodies in serum according t o their immunoglobulin classes (3). In this study, we applied these methods t o measurement of antibodies t o E. coli or B. fragilis in maternal serum and breast secretions, and antibodies t o E. coli in the cord serum and maternal serum of mother-infant pairs.
METHODS
SUBJECTS
Mothers were patients at Fitzsimons General Hospital who gave informed consent for the study. Seventeen (7 primiparous and 10 multiparous) mothers breast-fed their babies; 3 1 (18 primiparous and 13 multiparous) did not. BREAST FLUIDS A N D S E R A Venous blood was drawn from mothers just before delivery and 6 weeks after delivery. Colostrum and breast milk were collected by manual expression during the first 24 hr (day 1 ) and at 4 days and 6 weeks after delivery. Blood was allowed t o clot for 12 hr at 4', and the serum was collected after centrifugation. Colos;rum and milk were centrifuged (7,000 rpm for 60 min at 4 ), and a layer intermediate between fa; and the pellet was saved. The specimens were stored at -20 for 1 week t o 6 months before study.
BACTERIA
Bacteria were the same strains used in a previous study from this laboratory (3). A nonpathogenic strain of E. coli (ATCC no. 11775) was obtained from the American Type Culture Collection (ATCC), Rockville, Md. An ATCC strain was selected because of its availability for repeated study. Because of the rough nature of the E. coli, it could not be typed by the usual methods used in this laboratory. B. fragilis was isolated from a septicemic patient's blood. The bacteria were cultured (in an anaerobic atmosphere for B. fragilis) in Bacto brain-heart infusion broth (27), washed in physiologic saline, and stored in 1% formalinized saline.
ANTIBODY A N D IMMUNOGLOBULIN PREPARATIONS
Exocrine 11 S IgA was purified from colostrum by DEAEcellulose (28) ion exchange chromatography and filtration (22) through . Traces of IgM were removed from the 11 S IgA fraction by affinity column chromatography using Sepharose 4B (29) coupled t o rabbit antihuman IgM (26). The final IgA preparation was pure as determined by immunoelectrophoresis and double immunodiffusion against a rabbit antiserum t o whole human colostrum.
Rabbit anti-IgG globulin (7 S) was prepared as described previously (3) from rabbits that had been hyperimmunized with normal human serum IgG. Anti-IgA globulin was prepared by hyperimmunization of rabbits with human colostral 11 S IgA, absorption of the antiserum with human IgG, and precipitation of y-globulins by ammonium sulfate at 33% saturation (22). The preparation then was specifically purified by affinity chromatography with Sepharose 4B coupled t o human serum IgA. Antibodies eluted with 3 M NaSCN (7) were monospecific for cr chains of human IgA when tested by immunoelectrophoresis and double diffusion in agar gel against colostrum and serum. Specific antibodies, estimated by quantitative precipitation, comprised 60% of the total protein of the purified anti-IgA. IMMUNOGLOBULIN 
MEASUREMENTS
Immunoglobulins in serum and breast fluids were measured by radial immunodiffusion in antibody-containing agar (16).
Reference standards for serum IgG and IgA measurements were IgG and monomeric IgA prepared from normal human serum (3). For measurement of IgA in breast fluids, 11 S colostral IgA was the reference standard.
ANTIBODY MEASUREMENTS E. coli antibody concentrations were measured in all subjects and B. fragilis antibody concentrations were measured in 1 0 randomly selected mothers who were breast-feeding.
After absorption with E. coli and B. fragilis, the anti-IgG and anti-IgA globulins were labeled with ' 2 5 I (30) according t o the chloramine-T method (13); 1 mCi ~a '~' 1 was used t o label 1 mg protein.
The radioimmunoassay has been described in detail (3). Briefly, serum or colostrum was diluted in 0.01 M phosphatebuffered saline (PBS) containing 0.0075 M trisodium ethylenediaminetetraacetate (EDTA), pH 7.4, t o give an IgA concentration of about 0.5 mg/ml serum or 0.05 mg/ml colostrum. The fluids were incubated (4O for 6 0 min) with a suspension of either E. coli or B. fragilis (about 6 X 10' organisms). The bacteria were washed, resuspended in PBS-EDTA, and incubated (4' for 6 0 min) with radioiodinated anti-IgG or anti-IgA (400 ng antibody nitrogen in 0.5 ml PBS-EDTA). After further washing, radioactivity in the bacterial suspensions was counted in an automatic y-counter. A control aliquot of each fluid was handled identically except that it had been preabsorbed with the same species of bacteria that was added t o experimental samples. Radioactivity of bacteria that had been incubated in control sera was subtracted from that of bacteria incubated in experimental sera, and the net amount of anti-IgG or anti-IgA bound t o bacteria was determined by comparison t o a known amount of labeled antibody.
From the amount of anti-IgG or anti-IgA specifically bound t o the bacteria, the amount of IgG or IgA antibacterial antibody bound was estimated according t o the relation between the anti-IgG or anti-IgA and purified serum IgG, serum monomeric IgA, or 11 S colostral IgA in quantitative precipitin tests at equivalence. The ratio (milligram per milligram) of anti-IgA t o 11 S colostral IgA was 2.9 and t o serum IgA 2.4; the anti-IgG t o IgG ratio was 2.2.
After radioactivity was counted, turbidity of the bacterial suspensions was measured spectrophotometrically at 620 nm.
RESULTS SERUM A N D BREAST F L U I D IMMUNOGLOBULIN CONCENTRATIONS
The concentration of IgG in 10 specimens of cord blood was 8.1 f 1.3 (SD) mglml; in corresponding maternal sera it was 6.6 f 1.9 mgjml. The concentration of IgA at the time of delivery in sera of mothers who breast-fed their babies was 1.63 rf. 0.86 mgjml (Fig. 1) ; in those who did not, it was 1.79 f 1.32 mgjml. These differences are not statistically significant. In colostrum or breast milk, the IgA concentration was 36.7 f 25.33 mgjml a t day 1, 1.66 + 1.06 mgjml 4 days after delivery, and 0.71 * 0.31 mgjml 6 weeks after delivery (Fig.   1 ).
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SPECIFICITY O F RADIOIMMUNOASSAY fragilis and E. coli completely removed binding of IgA t o these
As in the previous study (3), specificity of the reactions between radiolabeled anti-human immunoglobulins and immunoglobulins bound t o bacteria was confirmed in the assay by blocking the reactions with a 10-fold excess of unlabeled antibody. Unlabeled anti-IgA completely blocked the specific binding of labeled anti-IgA t o serum-or colostrum-treated bacteria, whereas anti-IgG and anti-IgM had n o effect; similar specificity was demonstrated for the anti-IgG-IgG system when excess anti-IgA or anti-IgM was added. Specificity of the reactions between bacteria and breast secretions or serum was tested by measuring the antibody content of the fluids after absorption with bacteria. B. fragilis removed less than 8% of E. coli antibody activity, E. coli removed less than 5% of B. fragilis antibody activity, and a single absorption with B. bacteria. The spectrophotometric density of control and experimental specimens never differed by more than lo%, thus excluding the possibility that excessive loss of bacteria from the experimental samples had occurred.
ANTIBODY CONCENTRATIONS
Concentrations of antibacterial antibodies in sera or breast fluids were expressed as micrograms of antibody per milliliter of fluid or micrograms of antibody per milligram of either IgA or IgG. In breast fluids, concentrations of IgA antibodies reactive with E. coli were 14.8 f 13.9 pg/ml during day 1, 0.68 f 0.62 pg/ml on d a y 4, and 0.33 f 0.22 pg/ml 6 weeks after delivery (Fig. 2a) . In contrast to this abrupt decline in total amount of IgA antibody per milliliter of breast fluids during the 6-week period, the concentrations of specific antibody per milligram of IgA in d a y 1 colostrum (0.51 f 0.43), d a y 4 colostrum (0.41 f 0.34), and milk at 6 weeks (0.49 f 0.27) were virtually constant (Fig. 2b) . Maternal serum IgA antibody concentrations, expressed as micrograms of antibody per milliliter at the time of delivery (0.64 f 0.3 1) were about 0.05 those in colostrum on day 1, but 6 weeks later the concentrations in serum (0.57 f 0.24) and breast milk (0.33 f 0.22) were similar. By contrast, the amount of IgA antibody per milligram of IgA in serum both a t delivery (0.57 -+ 0.63 pglmg) and 6 weeks after delivery (0.51 * 0.63 pg/mg) was similar t o those in breast fluids.
The concentrations of IgA antibodies reactive with B. fragilis in maternal serum at delivery and in d a y 4 colostrum did not differ significantly from the IgA anti-E. coli concentrations in these fluids (Fig. 3) .
Concentrations of IgA antibodies in breast fluids and serum of individual mothers were not correlated.
The concentrations of IgG antibodies reactive with E. coli in 10 maternal sera at delivery were similar t o those in the corresponding cord sera (Fig. 4) .
No differences were found in the concentrations of IgA anti-E. coli antibodies in sera of nursing and non-nursing mothers either at delivery or 6 weeks later. In both groups, concentrations declined slightly but insignificantly during the 6-week period. Concentrations were similar t o those in a group of nonpregnant, nonlactating females (3). Since minimal cross-reactivity between antibodies t o E. coli and B. fragilis was demonstrated, it is assumed that bacterial antigens detected were specific for the species.
The amount of antibodies present in colostrum (micrograms of antibody per milliliter) during the first day of lactation is higher (23-30-fold) than the corresponding amount of IgA antibodies in serum. This generous quantity of colostral antibodies can b e accounted for almost entirely by the higher total concentration (21-fold) of IgA in day I colostrum than in serum. Both the total amount of antibody and total IgA in
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Cord M a t e r n a l C 1 C o r d M a t e r n a l Serum S e r u m S e r u m S e r u m colostrum fall abruptly after delivery so that b y the 4 t h postpartum day their levels are similar t o those in serum. In contrast t o the sharp decline in total amount of IgA antibody per unit of colostrum during the first few postpartum days, the amount of antibody per milligram of breast fluid IgA remains nearly constant at about 0.5 pg/mg. Uniformity in specific antibody content of colostral IgA during this short time might be expected because of secretion of preformed exocrine 11 S IgA. That values are similar, however, 6 weeks after delivery suggests that later in lactation the breast synthesizes o r secretes IgA of a constant specific antibody level. Because we found that the concentrations of IgA antibodies and total IgA in breast fluids are parallel, the specificity of the radioimmunoassay is particularly critical. We believe that the test of specificity (Results) excluded any possibility that nonspecific adherence of IgA t o bacteria was measured.
Concentrations of IgA in breast fluids in our study were comparable with those published previously (2). Others have reported a decline in the titers of E. coli agglutinins (9, 2 0 ) and IgA concentrations (2) in colostrum during the 1st postpartum week.
Mechanisms b y which breast milk antibodies are synthesized and secreted are largely unknown. Many authors ( I , 25), partly because of inability t o find serum antibodies corresponding to antibodies in colostrum, have doubted that serum antibodies are secreted by the breast. Results of this study indicate, however, that IgA antibodies t o B. fragilis and E. coli are present in serum and therefore available for transfer into breast secretions. Nevertheless, we concur with others that the majority of breast milk antibodies probably are synthesized locally, because breast fluid and serum IgA antibodies are not quantitatively correlated in individual subjects, agglutinating antibodies are absent from t h e colostrum of parentally immunized rabbits while serum antibody activity is high (8), cells in colostrum synthesize secretory type IgA (21), and colostral IgA has an 11 S dimeric configuration whereas serum IgA principally is a 7 S monomer (25).
Bacteroides outnumber coliforms by about 1,000 times in the adult gut (4), but we found similar concentrations of antibodies t o B. fragilis and E. coli in serum as well as in breast fluids. This finding is unexplained, but it may be evidence that B. fragilis evokes an antibody response less readily than E. coli or is less accessible t o antibody-forming sites in the intestinal mucosa.
The biologic role of colostral IgA antibodies in regulating the gut microflora is unclear. Some have proposed that the lower number of coliforms in intestinal contents of breast-fed infants than in artificially fed infants is related t o ingestion of antibodies t o E. coli (20) , although other factors might be equally or more important. The presence of antibodies t o B. fragili.7 in breast fluids suggests that such antibodies could suppress the growth of Bacteroides in the neonatal gut and thereby account for the relatively low numbers of these anaerobic bacteria in stools of breast-fed infants (17). Because of the importance of Bacteroides in gastrointestinal physiology (1 I), the role of ingested antibodies t o these and other indigenous anaerobes deserves further attention.
Results of this study indicate also that concentrations of serum antibacterial antibodies are not influenced by pregnancy or nursing. The levels of maternal IgA antibodies t o E. coli and B. fragilis a t delivery and 6 weeks later were similar, and levels in nursing mothers did not differ significantly from those in non-nursing mothers. Moreover, the antibody levels in these women were similar t o those we have reported in males and nonpregnant, nonlactating females (3).
Both the levels of IgG and concentrations of IgG anti-E. coli antibodies (micrograms per milliliter of serum) were slightly higher in cord blood than in maternal serum, but the differences fell short of statistical significance, perhaps because
